Regeneration of retinal ganglion cells
OwnerHongjun Liu, Xiaohu Wei +1inventors
InventorsHongjun Liu, Xiaohu Wei, Na Qiao
Life of this patent
Estimating the term…
Loading patent…
OwnerHongjun Liu, Xiaohu Wei +1inventors
InventorsHongjun Liu, Xiaohu Wei, Na Qiao
Estimating the term…
Provided herein are compositions and methods for regenerating retinal ganglion cells (RGCs) from retinal neuron cells by activating transcription factors such as one or more of Atoh7, Brn3B, Sox4, Sox11, or Ils1. The retinal neuron cells may be interneuron cells such as amacrine cells, horizontal cells, and bipolar cell. The regenerated RGCs can project axons into discrete subcortical brain regions and establish retina-brain connections. They can respond to visual stimulation and transmit electrical signals into the brain. Therefore, the regenerated RGCs can replace damaged or degenerated RGCs, thereby treating vision impairment or blindness. The methods are likewise applicable to degenerated, damaged, or aged RGCs to stimulate them to regrow functional axons, thereby rejuvenating these RGCs.
A method for preparing a mammalian cell responsive to visual signals, comprising increasing the biological activity, in a retinal neuron cell, of one or more genes selected from the group consisting of:
A method for improving the function of a retinal ganglion cell (RGC), comprising increasing the biological activity, in the RGC, of one or more genes selected from the group consisting of Atoh7, Brn3B, Sox4, Sox11, and Ils1.
A method for treating visual impairment or blindness in a subject in need thereof, comprising administering to the retina of the subject an agent capable of increasing the biological activity of one or more genes selected from the group consisting of Brn3B, Sox4, Atoh7, Sox11, and Ils1.
Dependencies are inferred from the claim text.